179 related articles for article (PubMed ID: 32820348)
21. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole-photoinduced polyomavirus-negative Merkel cell carcinoma.
Miyazawa H; Shimauchi T; Hashizume H; Masuda Y; Aoshima M; Ito T; Tokura Y
J Dermatol; 2019 Aug; 46(8):e287-e288. PubMed ID: 30859619
[No Abstract] [Full Text] [Related]
23. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Vanacker A; Fabré G; Van Dorpe J; Peetermans WE; Maes B
Am J Transplant; 2008 Apr; 8(4):877-80. PubMed ID: 18261173
[TBL] [Abstract][Full Text] [Related]
24. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.
Williams K; Mansh M; Chin-Hong P; Singer J; Arron ST
Clin Infect Dis; 2014 Apr; 58(7):997-1002. PubMed ID: 24363331
[TBL] [Abstract][Full Text] [Related]
25. Recall of provision of sun protection measures to patients with cystic fibrosis being prescribed voriconazole.
Cunningham L; Moran M; Keating C; McKone E; Gallagher C; Lally A
Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):341-2. PubMed ID: 26139441
[No Abstract] [Full Text] [Related]
26. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
[TBL] [Abstract][Full Text] [Related]
27. Adverse effects of voriconazole: Over a decade of use.
Levine MT; Chandrasekar PH
Clin Transplant; 2016 Nov; 30(11):1377-1386. PubMed ID: 27581783
[TBL] [Abstract][Full Text] [Related]
28. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Bongomin F; Harris C; Hayes G; Kosmidis C; Denning DW
PLoS One; 2018; 13(4):e0193732. PubMed ID: 29634721
[TBL] [Abstract][Full Text] [Related]
29. Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.
Cucchetto G; Cazzadori A; Conti M; Cascio GL; Braggio P; Concia E
Infection; 2015 Jun; 43(3):277-86. PubMed ID: 25432571
[TBL] [Abstract][Full Text] [Related]
30. Voriconazole-induced multiple squamous cell carcinomas in a patient with chronic lymphocytic leukemia.
Patel VA; Parikh SA; Nayyar PM; Ratner D
Dermatol Surg; 2015 Jun; 41(6):747-9. PubMed ID: 25984902
[No Abstract] [Full Text] [Related]
31. Pigmented squamous cell carcinoma in an adolescent following long-term treatment with voriconazole.
Verdú-Amorós J; Wilbrand JF; Mayser P; Gattenloehner S; Woessmann W
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27696679
[No Abstract] [Full Text] [Related]
32. Clinical efficacy of sequential therapy with voriconazole on COPD patients in acute phase with pulmonary aspergillosis and effects on cytokines and pulmonary functions.
Du JF; Chi YM; Song Z; Di QG; Shi J; Lv J; Mai ZT; Li M; Sun BH; Jiang MM
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1837-1842. PubMed ID: 29630134
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
35. High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.
Ng W; Takahashi A; Muto Y; Yamazaki N
J Dermatol; 2017 Oct; 44(10):1152-1155. PubMed ID: 28470790
[TBL] [Abstract][Full Text] [Related]
36. Incidence, demographics and surgical outcomes of cutaneous squamous cell carcinoma diagnosed in Northland, New Zealand.
Elliott BM; Douglass BR; McConnell D; Johnson B; Harmston C
N Z Med J; 2018 May; 131(1475):61-68. PubMed ID: 29771903
[TBL] [Abstract][Full Text] [Related]
37. Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
Lopez JL; Tayek JA
Drug Metab Dispos; 2016 Jan; 44(1):124-6. PubMed ID: 26502771
[TBL] [Abstract][Full Text] [Related]
38. Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma.
Williams K; Arron ST
JAMA Dermatol; 2016 Jun; 152(6):719-20. PubMed ID: 26982740
[No Abstract] [Full Text] [Related]
39. Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
Wu H; Xiong X; Han Q; Zhuo K; Wang K; Cheng D
J Mycol Med; 2023 Aug; 33(3):101385. PubMed ID: 37031653
[TBL] [Abstract][Full Text] [Related]
40. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
